- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
FDA demands more tests on new Lilly diabetes drug
October 19, 2010
J.K. WallEli Lilly and Co. will have to wait at least 18 months and conduct more studies before it wins market approval of a once-weekly
version of diabetes drug Byetta, a potential billion-dollar drug.
MoreRoche acquires assets from Virginia IT company
October 14, 2010
Terms of the deal, announced on Wednesday, call for Roche to acquire all the assets associated with Medical Automation Systems
Inc.'s point-of-care information technology connectivity system.
MoreLilly sues drug distributor over generic Zyprexa sales
September 29, 2010
Bloomberg NewsCelesio's Lloyds Pharmacy and Aah Pharmaceuticals businesses sold about 800,000 tablets of generic Zyprexa before agreeing
in 2008 to halt sales, Lilly said in a complaint filed in the High Court in London.
MoreCook stent could prevent more amputations, study finds
September 27, 2010
Bloomberg NewsA drug-coated stent from Indiana-based Cook Medical was more effective than standard therapy for patients with blockages in
an upper-leg artery, a study found.
MoreMedical equipment maker primed to expand in Greenwood
September 16, 2010
J.K. WallAdvantis Medical Inc., a maker of cases and trays for surgical instruments, plans to add more than 100 jobs in Greenwood over
the next five years.
MoreVoCare raises $2.2 million for telehealth device
September 13, 2010
J.K. WallThe local startup expects to raise another $1.3 million this year and launch pilots of a new mobile device connecting patients
with doctors.
MoreLilly wins reversal of class action in Zyprexa suit
September 10, 2010
Bloomberg NewsA U.S. appeals court in New York threw out a September 2008 ruling that said plaintiffs could pursue as a group claims that
Zyprexa marketing caused them to pay more for the drug than what it was worth. The plaintiffs were seeking $6.8 billion in
damages.
MoreLilly investing up to $150M in VC funds
September 8, 2010
Bloomberg NewsThe three venture funds, which will focus on drug development, may be worth a total of $750 million, up to $250 million each,
and Lilly will contribute as much as 20 percent of the money.
MorePoor economy keeping Wishard project costs down
September 8, 2010
Scott OlsonContractors starving for work are submitting more competitive bids, which so far has led to about $10 million in savings,
hospital official says.
MoreIndianapolis software firm RealMed acquired
September 2, 2010
IBJ StaffHealth care software firm RealMed Corp. will keep its base of operations in Indianapolis after being acquired by health information
exchange provider Availity LLC of Jacksonville, Fla. Terms of the deal announced Wednesday were not disclosed.
MoreAfter health reform, Lilly looking for more
September 1, 2010
J.K. WallThe health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives
of the
bill—and calling for further government efforts to help pharmaceutical research and development.
MoreLilly wins ban of generic Strattera pending appeal
August 31, 2010
Bloomberg NewsThe U.S. Court of Appeals for the Federal Circuit in Washington on Tuesday granted Lilly's request to prevent sales until
the court rules on a judge's decision invalidating a patent on the medicine.
MoreEndocyte's $86M IPO plan a boon for Indiana, investors
August 28, 2010
Greg AndrewsVenture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
MoreHealth insurer cash shifts to favor Republicans before election
August 27, 2010
Bloomberg NewsHealth insurers led by WellPoint Inc. are backing Republicans with campaign donations by an 8-to-1 margin, favoring the party
that's promised to repeal President Barack Obama's health-care overhaul if it wins back Congress.
MoreLilly wins further delay in sales of Strattera copies
August 26, 2010
Bloomberg NewsStrattera generated U.S. sales of $445.6 million last year, and each day that Lilly can fend off generic competition would
translate into an average $1.22 million in sales.
MoreDiabetes research pioneer Kirtley dies at 96
August 25, 2010
Associated PressDiabetics who control their disease with pills instead of frequent insulin injections can thank Dr. William R. Kirtley, a
groundbreaking Eli Lilly researcher.
MoreLilly woes take notch out of debt rating
August 25, 2010
J.K. WallEven with debt levels at Eli Lilly and Co. at paltry lows, a string of bad news finally forced Standard & Poor’s
to lower
its rating on the company’s senior unsecured debt. But the New York-based agency said it believes the Indianapolis-based
drugmaker will eventually break its string of bad luck on developing new products.
MorePearl IRB first firm in state to pre-screen clinical drug trials
August 21, 2010
Chris O'MalleyTwo former Eli Lilly and Co. employees launched the firm that promises to attract more clinical trial business to the state.
MoreLilly gains panel's backing to expand Cymbalta use
August 19, 2010
Bloomberg NewsOutside advisers to the Food and Drug Administration voted 8-6 Thursday in favor of a broader use of Cymbalta on the basis
of studies in lower back pain and osteoarthritis of the knee.
MoreLilly wins temporary ban on sales of Strattera copies
August 19, 2010
Bloomberg NewsThe invalidation of Lilly's Strattera patent opened the door for as many as 10 companies to sell generic versions of the drug,
which generated U.S. sales of $445.6 million last year as a treatment for attention deficit hyperactivity disorder.
MoreCancer drug developer Endocyte files for IPO
August 18, 2010
Scott OlsonThe company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet
to be determined.
MoreLilly Alzheimer's drug prospect only the latest to fail
August 18, 2010
Bloomberg NewsA dozen potential products designed to slow or stop clumps of protein from forming in the brain, a condition linked to the
disease since 1906, have failed in mid- to late-stage testing since 2003.
MoreLilly's Cymbalta helps chronic pain in U.S. review
August 17, 2010
Bloomberg NewsApproval for the millions of Americans with chronic back or knee pain may add more than $500 million, or 16 percent, to Cymbalta's
annual sales.
MoreLilly halts development of Alzheimer's drug
August 17, 2010
IBJ Staff and Associated PressStudies showed that the treatment did not slow the disease's progression. It's just the latest setback for the pharmaceutical
giant, which lost a patent lawsuit over a major drug last week and faces an unprecedented number of patent expirations through
2014.
MoreMedco to acquire United BioSource for $710M
August 16, 2010
IBJ Staff and Bloomberg NewsMedco operates an automated pharmacy and distribution center in Whitestown in Boone County, and it plans to employ more than
1,400 people there by 2012.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
If a television station wants to improve viewership, get rid of the local blackout. I was born by the brickyard, and have attended 15 or more races. I have children now, I won't attend unless circumstances are perfect. As those with growing families know, they never are. I'm always impressed that upwards of 250,000 people attend the 500. However, as a growing, or, more apt, sprawling city, Indianapolis and its immediate suburbs count almost 2.2 million. Show the race live, let the venue get a kick-back on revenues, and open-wheel racing might have a fighting chance to be relevant again. Just in time for those tax-payer lights to make sense.
John Moore, I too have had the same issue recently. A property next to my house was on the Land Bank and I was interested in purchasing. When I tried to contact Reggie, I got back emails that had nothing to do with what I asked about. Actually my latest response from him was on this past Friday. I had asked about how to buy the property and if it was still available. His response to me was to contact the mayor's office to get the schedule of his appearances. (???) Hopefully the city is able to do something to fix what this guy has done, it would be nice if they would take the properties back and sell them properly so land owners like me and you mother would have a fair chance.
I too work in the industry, with over 25 years of experience and your political spin has probably nothing to do with any rebranding. "Let's dress it up" would have nothing to do with the government "telling us how and what to eat." Give it a political rest. And being a producer for a radio show doesn't mean you've been involved in advertising and branding for 30 years.
Ms. Morris did not understand the ways of the business world, otherwise, like the IMS, she could have petitioned the State Legislature for a handout of State Funds for her charity work. Ms. Morris should consider becoming a state lobbyist for Lemonade Stand Operators.
David Copperfield!